TipRanks
Go Ultimate55% OFF

GMO Pepabo, Inc. (3633) AI Stock Analysis

JP:3633

GMO Pepabo, Inc.

(TSE/TYO:3633)

Select Model
Rating:67Neutral
Price Target:JPY 2,782.00â–²(17.78% Upside)
Action:downgraded
Date:08/18/26

The overall score of 67 reflects a company with solid financial fundamentals and an attractive valuation, but with significant near-term technical risk. The primary strengths are a pristine balance sheet, strong cash flows, and a very low P/E ratio. However, the stock's extremely overbought technical condition, with an RSI above 90, is a major headwind that tempers the overall outlook.

Positive Factors
Profitability RecoveryThe return to positive profitability after the 2023 loss indicates meaningful operational recovery and improved earnings capacity. If maintained, stronger operating and net margins can support reinvestment, shareholder returns, and greater resilience across the company’s web infrastructure and e-commerce services.
Negative Factors
Weak Top-Line GrowthFlat or declining revenue limits the company’s ability to expand earnings through scale and makes future profit gains more dependent on cost control. Without renewed demand across hosting, domains, e-commerce support, or content services, the recent profitability recovery may prove difficult to compound.

GMO Pepabo, Inc. (3633) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%40%JP:3633+18.77%EWJ+15.87%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
JPY 12.19B
Dividend Yield
2.84%
Average Volume (3M)
31.10K
Price to Earnings (P/E)
7.8
Beta (1Y)
0.53
Revenue Growth
-3.72%
EPS Growth
138.33%
Country
Japan
Employees
307
Sector
Technology
Sector Strength
61
Industry
Software - Infrastructure

GMO Pepabo, Inc. Business Overview & Revenue Model

Company Description

GMO Pepabo, Inc. delivers a variety of internet-based services tailored for individual consumers across Japan. The firm organizes its activities into four core divisions. Its Hosting segment supplies foundational services, including domain registrati...

GMO Pepabo, Inc. Financial Statement Overview

Summary

Strong overall financial health driven by a robust balance sheet (Score 87) and excellent cash flow generation (Score 82), offset by a mixed income statement (Score 68) due to stagnant revenue. The company has successfully deleveraged and turned profitable with high returns on equity.

Income Statement

68Positive

Balance Sheet

87Very Positive

Cash Flow

82Very Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue10.83B10.96B10.92B10.90B10.53B11.88B
Gross Profit5.84B5.96B5.78B5.93B6.08B6.73B
EBITDA1.68B1.44B1.47B84.16M1.12B1.36B
Net Income829.77M878.44M591.63M-628.79M510.09M715.41M
Balance Sheet
Total Assets10.67B11.32B11.47B10.95B11.52B8.91B
Cash, Cash Equivalents and Short-Term Investments2.02B5.75B4.92B4.36B3.61B3.62B
Total Debt400.00M857.45M1.19B1.48B1.57B172.15M
Total Liabilities8.24B8.52B9.08B9.14B8.83B5.96B
Stockholders Equity2.43B2.80B2.39B1.81B2.69B2.93B
Cash Flow
Free Cash Flow01.37B901.23M1.38B-708.88M338.84M
Operating Cash Flow01.46B1.21B1.78B-213.40M669.08M
Investing Cash Flow0236.62M-292.00M-325.63M-510.15M-278.35M
Financing Cash Flow0-859.23M-361.39M-702.63M712.28M-392.52M

GMO Pepabo, Inc. Technical Analysis

Technical Analysis SentimentNeutral
Last Price2362.00

Price Trends

50DMA2552.48Negative
100DMA2134.26Positive
200DMA2042.17Positive

Market Momentum

MACD-39.73Positive
RSI34.93Neutral
STOCH17.87Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3633, the sentiment is Neutral. The current price of 2362.00 is below the 20-day moving average (MA) of 2563.50, below the 50-day MA of 2552.48, and above the 200-day MA of 2042.17, indicating a neutral trend. The MACD of -39.73 indicates Positive momentum. The RSI at 34.93 is Neutral, neither overbought nor oversold. The STOCH value of 17.87 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:3633.

GMO Pepabo, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

JP:3633 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4431JP:443183OutperformJPY 74.15B28.79―0.63%20.70%56.44%
JP:3769JP:376969NeutralJPY 649.44B25.7721.67%1.99%13.19%25.73%
JP:3633JP:363367NeutralJPY 12.50B7.84―2.84%-3.72%138.33%
JP:4434JP:443462NeutralJPY 22.31B18.98―1.43%23.79%―
Sector *61Neutral$37.18B12.37-10.20%1.83%8.50%-7.62%
JP:3665JP:366559NeutralJPY 17.07B70.20―7.32%-1.71%-7.98%
JP:3778JP:377845NeutralJPY 121.34B44.23―0.16%25.84%71.45%

* Technology Sector Average

Performance Comparison

-25%0%25%50%JP:3633JP:3769JP:3665JP:3778JP:4431JP:4434Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
JP:3633 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:3633GMO Pepabo, Inc.2362.00373.2718.77%
JP:3769GMO Payment Gateway 8563.00298.003.61%
JP:3665ENIGMO, Inc.410.0025.066.51%
JP:3778SAKURA Internet Inc.3035.00-398.44-11.60%
JP:4431Smaregi, Inc.3790.00968.3134.32%
JP:4434Serverworks Co., Ltd.2801.00988.1654.51%

GMO Pepabo, Inc. Corporate Events

GMO Pepabo Lifts 2026 Profit Outlook and Dividend on Tax Benefit From Subsidiary Liquidation

Aug 13, 2026

GMO Pepabo, Inc. announced it will recognize an income tax benefit in the fiscal year ending December 31, 2026, stemming from deferred tax assets related to the special liquidation of consolidated subsidiary CN Co., Ltd. This tax effect significantly...

GMO Pepabo Lifts Profit Outlook Despite Lower First-Half Sales

Aug 13, 2026

GMO Pepabo reported consolidated net sales of ¥5.26 billion for the six months ended June 30, 2026, down 5.0% year on year, with operating profit falling 14.1% to ¥513 million but profit attributable to owners of parent surging 169.5% to &#...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 18, 2026